Zhang, Changfeng
University of Pennsylvania
3 papers on CoChatORCID 0000-0002-2864-5551
Most cited papers
- Verified
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine
CAR-T cell therapy researchChronic Lymphocytic Leukemia Research
Cited by 1,785
- Verified
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Fraietta, J. A., Beckwith, K. A., Patel, P. R., Ruella, M., Zheng, Z., Barrett, D. M., Lacey, S. F., Melenhorst, J. J., McGettigan, S. E., Cook, D. R., et al. (2016) · Blood
CAR-T cell therapy researchChronic Lymphocytic Leukemia Research
Cited by 474
- Verified
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Ghassemi, S., Nunez-Cruz, S., O'Connor, R. S., Fraietta, J. A., Patel, P. R., Scholler, J., Barrett, D. M., Lundh, S. M., Davis, M. M., Bedoya, F., et al. (2018) · Cancer Immunology Research
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 312
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free